News & Analysis as of

Listing Rules Hong Kong Research and Development

Hogan Lovells

HK’s new listing regime for innovative science and technology companies effective from 31 Mar 2023

Hogan Lovells on

Hong Kong Stock Exchange has launched a new listing regime for “Specialist Technology Companies” under Chapter 18C of the Listing Rules, effective from 31 March 2023. We provide a brief overview of the listing regime...more

Latham & Watkins LLP

Launch of HKSE’s New Listing Regime for Specialist Technology Companies

Latham & Watkins LLP on

From 31 March 2023, the listing framework will include innovative companies in frontier industries, creating more opportunities for investors in the Hong Kong capital market. The Stock Exchange of Hong Kong Limited (the...more

Hogan Lovells

HK new listing regime for pre-revenue or pre-profit innovative science and technology companies

Hogan Lovells on

Hong Kong Stock Exchange published a consultation paper proposing new listing regime for “Specialist Technology Companies” under a new chapter (Chapter 18C) of the Listing Rules, providing an alternative route for listing for...more

Skadden, Arps, Slate, Meagher & Flom LLP

Hong Kong Publishes Groundbreaking New Rules for Dual-Class Shares, Emerging and Innovative Sectors

After publishing the “New Board Concept Paper” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued a consultation paper on February 23, 2018, titled “A Listing Regime for Companies From Emerging...more

Jones Day

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

Jones Day on

The Hong Kong Stock Exchange recently published a Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors, and proposed to introduce a new chapter implementing the listing of...more

Skadden, Arps, Slate, Meagher & Flom LLP

Hong Kong Announces Groundbreaking New Rules for Dual-Class Share, High-Tech and Biotech Company Listings

After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23 February 2018 a consultation paper entitled “A Listing Regime for Companies From...more

Jones Day

Pre-Revenue Biotech Companies Cleared to List on Hong Kong Stock Exchange

Jones Day on

The Situation: The Hong Kong Stock Exchange’s failure to recognize that investors are able to evaluate biotech companies in the pre-revenue stages, and its consequent refusal to list those companies for trading, is viewed by...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide